The ApoE ε4 variant (a known risk factor for AD) is associated with significant metabolic changes in astrocytes at the earliest stages of the disease (Lindner et al., 2022; Nam et al., 2023; Zulfiqar et al., 2019). The gene discussed is APOE; the disease is Alzheimer disease.